import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æ——è‰¦æœ€çµ‚æ•´åˆç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# åˆå§‹åŒ– session_state
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = "ğŸ“š RUBY"

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === UI é«˜å°æ¯”åº¦èˆ‡ç·Šç·»åŒ– === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9; color: #1A1A1A;
        font-size: 19px !important; line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* éšæ®µæ–¹å¡Šï¼šæ·±è‰²æ¼¸å±¤èƒŒæ™¯ç¢ºä¿å°æ¯”åº¦ (åœ–ä¸€ä¿®å¾©) */
    .big-stage-card {
        border-radius: 10px; padding: 0px; box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        border: 2px solid transparent; background: white; margin-bottom: 4px; overflow: hidden;
    }
    .big-stage-header {
        font-size: 18px !important; font-weight: 900; color: white !important;
        padding: 8px; text-align: center; text-shadow: 1px 1px 2px rgba(0,0,0,0.3);
    }

    .card-p-tx { border-color: #1B5E20; }
    .header-p-tx { background: linear-gradient(135deg, #2E7D32, #1B5E20); } /* æ·±ç¶  */
    .card-p-mt { border-color: #0D47A1; }
    .header-p-mt { background: linear-gradient(135deg, #1565C0, #0D47A1); } /* æ·±è— */
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #EF6C00, #BF360C); } /* æ·±æ©˜ç´… */
    .card-r-mt { border-color: #4A148C; }
    .header-r-mt { background: linear-gradient(135deg, #6A1B9A, #4A148C); } /* æ·±ç´« */

    .sub-block {
        margin: 2px 4px; padding: 4px; border-radius: 6px; 
        background: #F8F9FA; border-left: 5px solid #455A64;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #263238;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="ğŸ“"] { background: #E1F5FE !important; border-left: 5px solid #0288D1 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 40px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•å°èˆªæ•¸æ“šåº«ï¼šå…¨éšæ®µã€MOCã€PSOC/PROC èˆ‡ å¾©ç™¼ç¶­æŒæ•‘æ´ ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "dMMR / MSI-H", "content": "ä¸€ç·šé¦–é¸æ–¹æ¡ˆï¼šå«é‰‘åŒ–ç™‚ + PD-1 æŠ‘åˆ¶åŠ‘ (RUBY/GY018/AtTEnd)ã€‚"},
            {"title": "pMMR / NSMP", "content": "é å¾Œå–æ±ºæ–¼ ER/Gradeã€‚ä¸€ç·šåŒ–ç™‚åŠ ç¶­æŒ (DUO-E)ã€‚äºŒç·šæ¨™é¶å…ç–« (KN775)ã€‚"},
            {"title": "POLE mutation", "content": "é å¾Œæ¥µä½³ã€‚æ—©æœŸå¯è€ƒæ…®æ²»ç™‚é™éš (De-escalation) ä»¥é™ä½ä½µç™¼ç—‡ã€‚"},
            {"title": "p53 mutation", "content": "ä¾µè¥²æ€§æœ€å¼·ã€‚å»ºè­°åŒ–æ”¾ç™‚ç©æ¥µä»‹å…¥ã€‚Serous å‹éœ€é©— HER2ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Maintenance Therapy", "content": "ä¸€ç·š IO æ²»ç™‚å¾Œå»¶çºŒç¶­æŒç›´åˆ°ç–¾ç—…é€²å±• (PD)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "æ¨™æº–äºŒç·šï¼šPembro + Lenva (MSS) æˆ–å–®è—¥ IO (GARNET)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "æ•‘æ´æ²»ç™‚å¾Œç¶­æŒç•¶å‰æœ‰æ•ˆæ–¹æ¡ˆç›´è‡³é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "æ‰‹è¡“ (PDS/IDS) + Carbo/Pacli Â± Bevã€‚IDS åŠ  HIPEC (van Driel)ã€‚"},
            {"title": "Mucinous (MOC) é‘‘å®š", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚IAæœŸå¯ä¿å®ˆã€‚ä¾µè¥²å‹å»ºè­°ç©æ¥µåŒ–ç™‚ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutation", "content": "Olaparib å–®è—¥ç¶­æŒ 2å¹´ (SOLO-1)ã€‚"}, 
            {"title": "HRD positive / BRCA wt", "content": "PAOLA-1 (Ola+Bev) æˆ– PRIMA (Nira)ã€‚"},
            {"title": "HRD negative", "content": "Niraparib ç¶­æŒ (PRIMA ITT) æˆ– Bevacizumabã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive Recur)", "content": "PFI > 6mã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP III) æˆ–å«é‰‘è¤‡æ–¹ã€‚"},
            {"title": "PROC (Resistant Recur)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "PARPi Maint", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒ (NOVA/ARIEL3/SOLO2)ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced (CCRT)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ Â± IO (A18) æˆ– èª˜å°åŒ–ç™‚ (INTERLACE)ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»è¡“ (LACC) æˆ–å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Maintenance", "content": "1L æ–¹æ¡ˆå¾Œæ¥çºŒç¶­æŒ (KEYNOTE-826)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro+åŒ–ç™‚Â±Bev (KN826) æˆ– Atezoçµ„åˆ (BEATcc)ã€‚äºŒç·š ADCã€‚"}]}
    ]
}

# --- 2. å¯¦è­‰é‡Œç¨‹ç¢‘è³‡æ–™åº« (25é …æ¥µé‡åŒ–è£œå®Œ) ---
milestone_db = [
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H"], "name": "ğŸ“š RUBY", "pharma": "GSK", "drug": "Dostarlimab + Carboplatin/Paclitaxel", 
     "pop_summary": "dMMR æ—ç¾¤æ ¸å¿ƒç ”ç©¶ï¼šæ­»äº¡é¢¨éšªé™ 68% (HR 0.32)ã€‚",
     "rationale": "PD-1 é˜»æ–· (PD-1 blockade) èˆ‡å«é‰‘åŒ–ç™‚å…·å‚™å”åŒå…ç–«åŸæ€§ç´°èƒæ­»äº¡ (ICD) æ•ˆæ‡‰ï¼Œé‡å° MMRd æ—ç¾¤é”æˆæ¥µé«˜åæ‡‰èˆ‡æŒä¹…æ‡‰ç­” (Durable Response)ã€‚",
     "regimen": "èª˜å°æœŸ (Induction): Dostarlimab 500mg Q3W + CP x6é€±æœŸ -> ç¶­æŒæœŸ (Maintenance): Dostarlimab 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["æ–°è¨ºæ–· FIGO Stage III-IV æˆ–é¦–æ¬¡å¾©ç™¼ä¹‹å­å®®å…§è†œç™Œ (EC)ã€‚", "åŒ…å«ç™Œè‚‰ç˜¤ (Carcinosarcoma) å‹æ…‹ã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éç³»çµ±æ€§æŠ—ç™Œæ²»ç™‚ã€‚", "æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…ã€‚"],
     "results": "dMMR: HR 0.32 (PFS), HR 0.30 (OS); ITT å…¨äººç¾¤ mOS 44.6m (vs 28.2m)."},
    
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H", "pMMR / NSMP"], "name": "ğŸ“š NRG-GY018", "pharma": "MSD", "drug": "Pembrolizumab + CP", 
     "pop_summary": "ä¸€ç·šä¸åˆ† MMR æ¨™ç«¿ï¼šdMMR PFS HR 0.30; pMMR HR 0.54ã€‚",
     "rationale": "åˆ©ç”¨ ICI èˆ‡å‚³çµ±åŒ–ç™‚è¯ç”¨ï¼Œæ“´å¤§ä¸€ç·šä»‹å…¥ä¹‹ç”Ÿå­˜ç²ç›Šã€‚",
     "regimen": "Pembrolizumab 200mg Q3W + CP x6é€±æœŸ -> ç¶­æŒ 400mg Q6W æœ€é•· 2å¹´ã€‚",
     "outcomes": "dMMR PFS HR 0.30; pMMR PFS HR 0.54."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["pMMR / NSMP"], "name": "ğŸ“š DUO-E", "pharma": "AZ", "drug": "Durvalumab + CP â†’ç¶­æŒ Â± Olaparib", 
     "pop_summary": "ä¸€ç·šç¶­æŒç­–ç•¥ï¼šä¸‰è—¥çµ„ (Ola) pMMR PFS HR 0.57ã€‚",
     "rationale": "æ¢ç´¢ PARPi å°æ–¼ pMMR æ‚£è€…åœ¨å…ç–«ç¶­æŒéšæ®µçš„å¢æ•èˆ‡å”åŒä½œç”¨ã€‚"},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H"], "name": "ğŸ“š AtTEnd", "pharma": "Roche", "drug": "Atezolizumab + CP", 
     "pop_summary": "ä¸€ç·šæ™šæœŸç ”ç©¶ï¼šdMMR PFS HR 0.36; ITT OS HR 0.82ã€‚",
     "outcomes": "dMMR PFS HR 0.36; ITT OS HR 0.82 (P=0.048)."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "pharma": "MSD/Eisai", "drug": "Lenvatinib + Pembro", 
     "pop_summary": "pMMR/MSS äºŒç·šæ¨™æº–ï¼šOS 17.4m vs 12.0m (HR 0.68)ã€‚",
     "rationale": "çµåˆ VEGF-TKI èˆ‡å…ç–«æŠ‘åˆ¶åŠ‘ï¼Œå…‹æœ MSS è…«ç˜¤ä¹‹å…ç–«å†·ç‹€æ…‹ã€‚"},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š GARNET", "pharma": "GSK", "drug": "Dostarlimab å–®è—¥", 
     "pop_summary": "MSI-H å¾Œç·šå–®è—¥å…ç–«ï¼šORR é” 45.5%ã€‚",
     "outcomes": "dMMR ORR 45.5%; DOR (åæ‡‰æŒçºŒæ™‚é–“) æœªé”åˆ°ã€‚"},

    # --- Cervical Published ---
    {"cancer": "Cervical", "pos": "Locally Advanced (CCRT)", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "pharma": "MSD", "drug": "Pembrolizumab + CCRT", 
     "pop_summary": "LACC æ¨™æº–æ–¹æ¡ˆï¼š36å€‹æœˆ OS ç‡ 82.6% (HR 0.67)ã€‚",
     "rationale": "å°‡å…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘æ•´åˆå…¥å±€éƒ¨æ™šæœŸ (LACC) æ ¹æ²»æ¨™æº–ã€‚"},

    {"cancer": "Cervical", "pos": "Locally Advanced (CCRT)", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š INTERLACE", "pharma": "UCL", "drug": "Induction Carbo/Pacli x6", 
     "pop_summary": "èª˜å°åŒ–ç™‚åƒ¹å€¼ï¼š5å¹´ OS ç‡ 80% vs 72% (HR 0.60)ã€‚",
     "outcomes": "5yr OS 80% (vs 72%); PFS HR 0.60."},

    {"cancer": "Cervical", "pos": "Locally Advanced (CCRT)", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š CALLA", "pharma": "AZ", "drug": "Durvalumab + CCRT", 
     "pop_summary": "é™°æ€§è©¦é©—æé†’ï¼šDurva+CCRT æœªé” PFS æ”¹å–„ (HR 0.84)ã€‚",
     "outcomes": "PFS HR 0.84 (P=NS)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "pharma": "MSD", "drug": "Pembro + Chemo Â± Bev", 
     "pop_summary": "R/M ä¸€ç·šé»ƒé‡‘æ¨™æº–ï¼šå…¨äººç¾¤æ­»äº¡é¢¨éšªé™ 37% (OS HR 0.63)ã€‚",
     "outcomes": "OS HR 0.63 (ITT); HR 0.60 (CPSâ‰¥1)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc", "pharma": "Roche", "drug": "Atezo + Chemo + Bev", 
     "pop_summary": "ä¸€ç·šå¾©ç™¼/è½‰ç§»ï¼šPFS HR 0.62; OS HR 0.68ã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "pharma": "Regeneron", "drug": "Cemiplimab å–®è—¥", 
     "pop_summary": "äºŒç·šå¾Œ OS åŸºçŸ³ï¼šOS 12.0m vs 8.5m (HR 0.69)ã€‚"},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š innovaTV 301", "pharma": "Genmab", "drug": "Tisotumab Vedotin (ADC)", 
     "pop_summary": "å¾Œç·š ADC çªç ´ï¼šOS HR 0.70; ORR 17.8% (vs 5.2%)ã€‚",
     "rationale": "æ¨™é¶çµ„ç¹”å› å­ (TF) ä¹‹ ADCï¼Œè§£æ±ºå¾Œç·šåŒ–ç™‚è€è—¥ç“¶é ¸ã€‚"},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "pharma": "CCTG", "drug": "Simple Hysterectomy", 
     "pop_summary": "æ‰‹è¡“é™éšå¯¦è­‰ï¼šå–®ç´”åˆ‡é™¤ä¸åŠ£æ–¼æ ¹æ²»è¡“ (3yr å¾©ç™¼ 2.5%)ã€‚"},

    # --- Ovarian Published ---
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation"], "name": "ğŸ“š SOLO-1", "pharma": "AZ", "drug": "Olaparib ç¶­æŒ", 
     "pop_summary": "BRCAm é‡Œç¨‹ç¢‘ï¼š7å¹´å­˜æ´»ç‡ 67% (HR 0.33)ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt", "HRD negative"], "name": "ğŸ“š PRIMA", "pharma": "GSK", "drug": "Niraparib ç¶­æŒ", 
     "pop_summary": "å…¨äººç¾¤ä¸€ç·šç¶­æŒï¼šHRD+ PFS HR 0.43ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š PAOLA-1", "pharma": "AZ", "drug": "Olaparib + Bevacizumab", 
     "pop_summary": "HRD+ é»ƒé‡‘çµ„åˆï¼š5å¹´ OS ç‡ 75.2% (HR 0.62)ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation", "HRD positive / BRCA wt"], "name": "ğŸ“š ATHENAâ€“MONO", "pharma": "Clovis", "drug": "Rucaparib ç¶­æŒ", 
     "pop_summary": "ITT PFS 28.7m (HR 0.52)ã€‚"},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š NOVA", "pharma": "GSK", "drug": "Niraparib å¾©ç™¼ç¶­æŒ", 
     "pop_summary": "å¾©ç™¼ç¶­æŒåŸºçŸ³ï¼šgBRCA HR 0.27; non-gBRCA HR 0.45ã€‚"},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š ARIEL3", "pharma": "Clovis", "drug": "Rucaparib å¾©ç™¼ç¶­æŒ", 
     "pop_summary": "ç¶­æŒæ²»ç™‚ç²ç›Šï¼šHRD+ PFS HR 0.32ã€‚"},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["PARPi Maint"], "name": "ğŸ“š SOLO2", "pharma": "AZ", "drug": "Olaparib å¾©ç™¼ç¶­æŒ", 
     "pop_summary": "BRCAm é•·æœŸ OSï¼šmOS 51.7m vs 38.8m (HR 0.74)ã€‚"},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š DUO-O", "pharma": "AZ", "drug": "Durva+Ola+Bev ç¶­æŒ", 
     "pop_summary": "å…ç–«çµ„åˆæ½›åŠ›ï¼šHRD+ PFS HR 0.49ã€‚"},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "name": "ğŸ“š MIRASOL", "pharma": "ImmunoGen", "drug": "Mirvetuximab", 
     "pop_summary": "PROC OS çªç ´ï¼šmOS 16.4m vs 12.7m (HR 0.67)ã€‚"},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š HIPEC (van Driel)", "pharma": "NEJM 2018", "drug": "Surgery + HIPEC", 
     "pop_summary": "IDS æ™‚åŠ ç†±åŒ–ç™‚ï¼šmOS 45.7m vs 33.9m (HR 0.67)ã€‚"},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PSOC (Sensitive)"], "name": "ğŸ“š DESKTOP III", "pharma": "NEJM 2021", "drug": "Secondary Surgery", 
     "pop_summary": "äºŒæ¬¡æ¸›ç©åƒ¹å€¼ï¼šå®Œå…¨åˆ‡é™¤è€… mOS é” 53.7mã€‚"},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION", "pharma": "NEJM 2019", "drug": "No Lymphadenectomy", 
     "pop_summary": "è‡¨åºŠ LN é™°æ€§å…æ¸…æƒï¼šOS ç„¡å·®ç•° (HR 1.06)ã€‚"},
]

# --- 3. æ‹›å‹Ÿä¸­è‡¨åºŠè©¦é©—è³‡æ–™åº« (8é …æ ¸å¿ƒæ¥µé‡åŒ–) ---
ongoing_trials = [
    {"cancer": "Endometrial", "name": "ğŸ“ MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["Maintenance Therapy"], "type": "Ongoing",
     "pop_summary": "æ¨™é¶ Trop-2 ADC å”åŒå…ç–«ï¼šé‡å° pMMR æ—ç¾¤æŒ‘æˆ°ä¸€ç·šç¶­æŒæ¨™æº–ã€‚",
     "rationale": "åˆ©ç”¨ Trop-2 ADC (Sac-TMT) å¼•ç™¼ä¹‹ ICD èª¿ç¯€è…«ç˜¤å¾®ç’°å¢ƒï¼Œå¼·åŒ– PD-1 æŠ‘åˆ¶åŠ‘ (Pembrolizumab) åœ¨ pMMR æˆ– NSMP æ‚£è€…ä¸­çš„æ‡‰ç­”æ·±åº¦èˆ‡æŒçºŒæ™‚é–“ã€‚",
     "regimen": "Pembrolizumab 400mg Q6W + Sac-TMT 5mg/kg Q6W ç›´è‡³é€²å±•ã€‚",
     "inclusion": ["æ–°è¨ºæ–· pMMR å­å®®å…§è†œç™Œ (ä¸­å¿ƒæª¢æ¸¬)ã€‚", "FIGO III/IV æœŸã€å«é‰‘åŒ–ç™‚ + Pembro å¾Œé” CR/PRã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éé‡å°æ™šæœŸç—…ç¶ä¹‹ç³»çµ± IO æ²»ç™‚ã€‚", "å­å®®è‚‰ç˜¤ (Sarcoma)ã€‚"]},

    {"cancer": "Endometrial", "name": "ğŸ“ GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "type": "Ongoing",
     "pop_summary": "Trop-2 ADC æ•‘æ´æ²»ç™‚ï¼šè§£æ±ºé‰‘é¡èˆ‡å…ç–«å¤±æ•—ä¹‹è‡¨åºŠå›°å¢ƒã€‚",
     "rationale": "åˆ©ç”¨ SN-38 è¼‰è·å¼•ç™¼ DNA æå‚·ï¼Œå°ˆæ”»é‰‘é¡åŠå…ç–«æª¢æŸ¥é»æŠ‘åˆ¶åŠ‘å¤±æ•—å¾Œä¹‹å¾©ç™¼æ€§å…§è†œç™Œæ‚£è€…ã€‚",
     "regimen": "Sacituzumab govitecan 10mg/kg (Day 1, Day 8) Q21Dã€‚",
     "inclusion": ["å¾©ç™¼æ€§ EC (ä¸å«è‚‰ç˜¤)ã€‚", "å…ˆå‰æ›¾æ¥å—é‰‘é¡åŒ–ç™‚åŠ PD-1/L1 å¤±æ•—ã€‚"],
     "exclusion": ["å…ˆå‰ç”¨éé‡å° Trop-2 ä¹‹ ADC è—¥ç‰©ã€‚", "æ´»å‹•æ€§ CNS è½‰ç§»ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ FRAmework-01", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)", "PSOC (Sensitive)"], "type": "Ongoing",
     "pop_summary": "FRÎ± ADC è·¨çµ„è‡¨åºŠï¼šè¯ç”¨ VEGF æŠ‘åˆ¶åŠ‘æå‡è…«ç˜¤æ»²é€èˆ‡æ®ºå‚·åŠ›ã€‚",
     "rationale": "é€é LY4170156 (FRÎ± ADC) ç²¾æº–æ¨™é¶èˆ‡ Bevacizumab ç”¢ç”Ÿè¡€ç®¡é‡å¡‘å”åŒä½œç”¨ï¼Œå¢å¼·è—¥ç‰©åœ¨ PROC/PSOC æ‚£è€…è…«ç˜¤åŸºè³ªä¸­çš„æ¿ƒåº¦ã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["ç¶“æª¢æ¸¬ FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œä¸€åŠ‘é‰‘é¡å¾Œ 90â€“180 å¤©å…§é€²å±• (PROC)ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant)"], "type": "Ongoing",
     "pop_summary": "é‡å° OCCC é€æ˜ç´°èƒç™Œï¼šåˆ©ç”¨é›™é‡é˜»æ–·æ”¹å–„å…¶ç‰¹æœ‰å…ç–«æŠ‘åˆ¶å¾®ç’°å¢ƒã€‚",
     "rationale": "OCCC å…·å‚™ç¨ç‰¹åŸºå› åœ–è­œèˆ‡é«˜åº¦å…ç–«æŠ‘åˆ¶ï¼Œçµ„åˆ IO + anti-VEGF æ—¨åœ¨èª˜å°å…ç–«æ‡‰ç­”ã€‚"},

    {"cancer": "Ovarian", "name": "ğŸ“ DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "P-MT", "sub_pos": ["HRD negative"], "type": "Ongoing",
     "pop_summary": "HER2 ADC é€²å…¥ç¶­æŒéšæ®µï¼šæ—¨åœ¨æ¸…é™¤ HER2 è¡¨ç¾ä¹‹å¾®å°æ®˜ç•™ç—…ç¶ã€‚",
     "rationale": "æ¨™é¶ HER2 ADC ä¹‹æ¥µé«˜ DAR (8) å„ªå‹¢ï¼Œæ–¼åŒ–ç™‚ç©©å®šå¾Œç²¾æº–æ¸…é™¤æ®˜å­˜ç—…ç¶ã€‚"},
]

# --- 4. å‹•æ…‹æ¨¡å‹èˆ‡ AI åª’åˆåŠ©ç† ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = next((m for m in available_models if 'gemini-1.5-flash' in m), None)
        if not target_model: target_model = next((m for m in available_models if 'gemini-pro' in m), None)
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# å´é‚Šæ¬„ AI åŠ©ç†
with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…æ•¸æ“šæ·±åº¦åˆ†æ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (å«åˆ†æœŸ/ç´°èƒ/æ¨™è¨˜)", placeholder="ä¾‹å¦‚ï¼šEC IIIæœŸ, p53 mutation, HER2 2+...", height=220)
        if st.button("ğŸš€ é–‹å§‹åˆ†æ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚è«‹åƒè€ƒå¯¦è­‰åº«ï¼š{milestone_db} åŠæ‹›å‹Ÿä¸­ï¼š{ongoing_trials}ã€‚æä¾›æ²»ç™‚å»ºè­°ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 5. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 æ——è‰¦å¯¦è­‰æ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            rel_trials = [t for t in (milestone_db + ongoing_trials) if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"{t.get('pharma', 'N/A')} | {t['name']} | {t['drug']}"
                with st.popover(label, use_container_width=True):
                    st.success(f"**æ ¸å¿ƒçµè«–:** {t.get('pop_summary', 'è©³è¦‹è©³ç´°çœ‹æ¿ã€‚')}")
                    unique_key = f"sync_{t['name']}_{cancer_type}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=unique_key):
                        st.session_state.selected_trial = t['name']
                        st.rerun() # ç„¡ç¸«è¯å‹•ä¿®å¾©
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 6. æ·±åº¦æ•¸æ“šçœ‹æ¿ (Bottom Selector) ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠç ”ç©¶æ¥µé‡åŒ–æ•¸æ“šåº« (Published Milestones & Ongoing Trials)")
all_list = milestone_db + ongoing_trials
filtered_names = [t["name"] for t in all_list if t["cancer"] == cancer_type]

try: curr_idx = filtered_names.index(st.session_state.selected_trial)
except: curr_idx = 0

selected_name = st.selectbox("ğŸ¯ å¿«é€Ÿé»é¸ç ”ç©¶ä»¥æŸ¥é–±è©³ç´°æ•¸æ“šï¼š", filtered_names, index=curr_idx, key="trial_selector")
st.session_state.selected_trial = selected_name
t = next(it for it in all_list if it["name"] == selected_name)

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.3, 1])
with r1:
    st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
    st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
    st.write(f"**è©³ç´°çµ¦è—¥æ–¹æ¡ˆ (Dosing Protocol):** {t.get('regimen', 'è«‹åƒè€ƒç‰¹å®šè©¦é©—åˆ†çµ„åŠ‘é‡èªªæ˜ã€‚')}")
    st.success(f"**ç§‘å­¸ç†æ“š (Scientific Rationale):** {t['rationale']}")
    

with r2:
    st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Evidence (ç”Ÿå­˜èˆ‡ç·©è§£æ•¸æ“š)</b></div>", unsafe_allow_html=True)
    st.markdown(f"""
        <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
            <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics (PFS/OS/HR/ORR)</div>
            <div class='hr-big-val'>{t.get('results', t.get('outcomes', 'Ongoing'))}</div>
        </div>
    """, unsafe_allow_html=True)
    

st.divider()
r3, r4 = st.columns(2)
with r3:
    st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (é—œéµç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for inc in t.get('inclusion', ['ç¬¦åˆåˆ†å­åˆ†å‹ (MMR/BRCA/HRD) èˆ‡å‰ç·šæ²»ç™‚è¦å®šã€‚']): st.write(f"â€¢ **{inc}**")
with r4:
    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (é—œéµæ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', ['æ’é™¤é¡¯è‘—è‡Ÿå™¨åŠŸèƒ½ä¸å…¨ã€æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…æˆ–è‚ºéƒ¨çº–ç¶­åŒ–å²ã€‚']): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
